Transform Lives with Cutting-Edge Ketamine Infusion Therapy: Join the KRI 2023 Mini-Fellowship Intensive Training Program for Clinicians
The Ketamine Research Institute Launches 2023 "Mini-Fellowship" Training Program for Clinicians
The Ketamine Research Institute has recently announced the launch of its new 2023 "Mini-Fellowship" intensive training course for clinicians. The program aims to equip clinicians with the knowledge and skills to administer ketamine infusion therapy safely and effectively.
The program is led by Dr. Gerald W. Grass, a nationally recognized expert in ketamine therapy, who has been instructing physicians, fellows, and government organizations such as the Veterans Administration and the Department of Defense in ketamine therapy since 2013.
Meeting and Exceeding APA and ASA Guidelines for Ketamine Therapy Training
The "Mini-Fellowship" intensive training course is tailored to meet or exceed the recommendations for clinician training in ketamine infusion therapy by leading medical organizations such as the American Psychiatric Association (APA) and the American Society of Anesthesiologists (ASA). This commitment to rigorous standards underscores the institute's dedication to providing the highest level of education and training for clinicians seeking to incorporate ketamine therapy into their practices.
A Comprehensive Educational Experience with Evidence-Based Didactic Lectures and Hands-On Clinical Experiences
The comprehensive educational experience includes evidence-based didactic lectures, interactive discussions, case studies, and hands-on clinical experiences administering ketamine infusions. What sets this program apart from other ketamine infusion training programs is that it takes place at a fully operational ketamine center. In addition, it provides trainees with supervised "hands-on" clinical infusion experience under the guidance of more experienced clinicians, allowing them to experience a ketamine infusion personally.
Unique Personal Ketamine Experience for Deeper Understanding of Ketamine Therapy
"Our program is designed to provide clinicians with the most comprehensive and up-to-date training in ketamine infusion therapy," said Dr. Grass. "Our unique personal ketamine experience sets us apart from other programs and provides our trainees with a deeper understanding of the phenomenological aspects of ketamine therapy. This experience also enables clinicians to develop valuable insights into the 'ketamine experience,' which can help them better understand and treat patients receiving this innovative therapy."
Personalized Learning and Practical Experience for Building Confidence in Ketamine Infusion Therapy
The training program features a comprehensive didactic curriculum that covers a range of critical topics, including advanced pharmacokinetic dosing strategies and a Precision Medicine approach to patient selection and evaluation. Participants will have ample opportunities to observe and participate in supervised clinical infusion sessions, which provide invaluable hands-on experience and help to build confidence in administering ketamine infusions to patients.
Advanced Knowledge and Expertise in Administering Ketamine Infusions Safely and Effectively
Upon completing the "Mini-Fellowship" intensive training course, participants will receive a certificate of completion that attests to their advanced knowledge and expertise in administering ketamine infusions safely and effectively. Trainees will be able to confidently diagnose, treat, and manage a range of psychiatric and chronic pain conditions using ketamine therapy.
Applications Now Open for the "Mini-Fellowship" Intensive Training Course.
Applications for the "Mini-Fellowship" intensive training course are now open. For more information or to apply, interested individuals can visit the Ketamine Research Institute's website at www.ketamineinstitute.com.
The Ketamine Research Institute's "Mini-Fellowship" intensive training course is an excellent opportunity for clinicians seeking to incorporate ketamine therapy into their practices. With its comprehensive curriculum, personalized learning, and practical experience, the program provides participants with the skills and knowledge they need to administer ketamine infusions safely and effectively.
The Best Clinical Training Available:
Ketamine therapy is a rapidly growing area of medicine, and it's important for physicians to stay up-to-date on the latest advancements. If you are a clinician interested in providing ketamine-based therapy to your patients and want the best clinical training available, consider enrolling in KRI's “Mini-Fellowship” program.
This intensive training program will provide you with everything you need to get started using ketamine in your practice - from didactic lectures led by expert educators to hands-on clinical experiences at a fully operational infusion center. You'll also have access to ongoing personal mentoring from experienced clinicians throughout the duration of the program and beyond. Don't miss this opportunity to receive comprehensive training in this cutting-edge therapeutic modality - sign up today!
About the Ketamine Research Institute
The Ketamine Research Institute was established to help advance and perfect ketamine therapy for a wide range of chronic diseases. The Ketamine Research Institute is a highly focused and specialized center dedicated exclusively to developing new ketamine treatments, expanding the medical uses of ketamine treatment through clinical research, and educating and training clinicians worldwide in the safe, secure, and effective use of advanced ketamine therapy.
Clinician Training Programs
The Ketamine Research Institute "Mini-Fellowship" Intensive Training Program for Clinicians provides an advanced Precision Medicine-based approach and Target-Controlled Infusion methodology to ketamine infusion therapy that takes ketamine therapy to the next level.
The KRI training program provides the most comprehensive educational experience available, including evidence-based didactics, supervised "hands-on" clinical experience, and individual experiential training. It is the only program that meets or exceeds all American Psychiatric Association and American Society of Anesthesiologists training recommendations. It also complies with recent laws on the safe administration of ketamine (UT-58-1-509), promoting more effective, safe, and uniform protocols for ketamine infusion therapy.
For clinicians who want to learn more about ketamine-based therapy and a Precision Medicine approach to optimized patient care, contact the Ketamine Research Institute at (800) 850-6979. To learn more, please visit ketamineinstitute.com.
Gerald Grass MD
Ketamine Research Institute